Your account is not claimed yet. You can sign up with ORCID to claim your account.

Adam S Komorowski (A S Komorowski)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Antimicrobial agents and chemotherapy

Open forum infectious diseases

Medical humanities

McMaster University

University of Toronto (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

McMaster University

Canada

Resident Physician, Medical Microbiology :: Pathology and Molecular Medicine

Education History

University of Toronto

Canada

BSC :: Microbiology and Immunology

Publications

Adam S Komorowski, Carson Ka-Lok Lo, Andrew K Kapoor, Marek Smieja, Mark Loeb, Dominik Mertz, Anthony D Bai
More than a decade since the latest CONSORT non-inferiority trials extension: do infectious diseases trials do enough? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Anthony D Bai, Carson K L Lo, Adam S Komorowski, Mallika Suresh, Kevin Guo, Akhil Garg, Pranav Tandon, Julien Senecal, Olivier Del Corpo, Isabella Stefanova, Clare Fogarty, Guillaume Butler-Laporte, Emily G McDonald, Matthew P Cheng, Andrew M Morris, Mark Loeb, Todd C Lee
How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and Observational Studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 75 (8) (2022)
Anthony D Bai, Carson K L Lo, Adam S Komorowski, Mallika Suresh, Kevin Guo, Akhil Garg, Pranav Tandon, Julien Senecal, Olivier Del Corpo, Isabella Stefanova, Clare Fogarty, Guillaume Butler-Laporte, Emily Gibson McDonald, Matthew Pellan Cheng, Andrew M Morris, Mark Loeb, Todd C Lee
What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality. Open forum infectious diseases 9 (5) (2022)
Anthony D Bai, Adam S Komorowski, Carson K L Lo, Pranav Tandon, Xena X Li, Vaibhav Mokashi, Anna Cvetkovic, Vanessa R Kay, Aidan Findlater, Laurel Liang, Mark Loeb, Dominik Mertz
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antibiotic Therapies: A Systematic Review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (7) (2021)
Adam S Komorowski, Anthony D Bai, Anna Cvetkovic, Omar Mourad, Carson K L Lo, Xena X Li, Vaibhav Mokashi, Aidan Findlater, Donald Brody Duncan, Charlotte Fuller, Daniela L Leto, Deborah Yamamura, Dominik Mertz
Are antifungal non-inferiority trials at risk of eroding effectiveness because of bio-creep? A secondary analysis of a systematic review. Antimicrobial agents and chemotherapy (2021)
Anthony D Bai, Adam S Komorowski, Carson K L Lo, Pranav Tandon, Xena X Li, Vaibhav Mokashi, Anna Cvetkovic, Aidan Findlater, Laurel Liang, Mark Loeb, Dominik Mertz
Novel Antibiotics May Be Noninferior but Are They Becoming Less Effective?: a Systematic Review. Antimicrobial agents and chemotherapy 64 (11) (2020)
Adam S Komorowski, Rossanna C Pezo
Untapped "-omics": the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment. Breast cancer research and treatment 179 (2) (2019)
Adam S Komorowski, Sang Ik Song
A politics of the senses: the political role of theKing's-Evil in Richard Wiseman's Severall Chirurgicall Treatises. Medical humanities 45 (3) (2018)

Adam S Komorowski.css-eqlu8i{font-size:small;padding-left:4px;} (A S Komorowski)

Publication Activity (10 Years)

Top Topics

Top Venues

Adam S Komorowski (A S Komorowski)